Advertisement
Research Article| Volume 2, ISSUE 1, P123-135, March 1982

Clinical Applications of HLA Typing

  • Herbert A. Perkins
    Correspondence
    Corresponding author: Irwin Memorial Blood Bank of the San Francisco Medical Society, 270 Masonic Avenue, San Francisco, California 94118
    Affiliations
    Scientific Director, Irwin Memorial Blood Bank of the San Francisco Medical Society; Clinical Professor of Medicine, University of California, San Francisco Medical Center, San Francisco, California
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)31057-6
Clinical Applications of HLA Typing
Previous ArticleDiagnosis, Prevention, and Therapy in Hemolytic Disease of the Newborn
Next ArticleRecent Advances in Blood Groups
      This paper is only available as a PDF. To read, Please Download here.
      HLA typing has proved to be a valuable and versatile clinical tool, permitting more successful renal transplantation, platelet transfusion, and paternity testing, and even serving as a diagnostic test for ankylosing spondylitis. HLA typing of a family can indicate which relatives are at highest risk for diseases such as hemochromatosis and juvenile-onset diabetes mellitus.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ayoub G.
        • Park M.S.
        • Terasaki P.I.
        • et al.
        B cell antibodies and crossmatching.
        Transplantation. 1980; 29: 227
        • Bensinger W.I.
        • Baker D.A.
        • Buckner C.D.
        • et al.
        Immunoadsorption for removal of A and B blood-group antibodies.
        N. Engl. J. Med. 1981; 304: 160
        • Beizer F.O.
        • Fortmann J.L.
        • Salvatierra O.
        • et al.
        Is HLA-A typing of clinical significance in cadaver renal transplantation?.
        Lancet. 1974; 1: 774
        • Brand A.
        • van Leeuwen A.
        • Eernisse J.G.
        • et al.
        Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
        Blood. 1978; 51: 781
        • Cochrum K.C.
        • Perkins H.A.
        • Payne R.O.
        • et al.
        The correlation of MLC with graft survival.
        Transplantation Proc. 1973; 5: 391
        • Cudworth A.G.
        • Woodrow J.C.
        Evidence for HL-A-linked genes in “juvenile” diabetes mellitus.
        Br. Med. J. 1975; 3: 133
        • Dausset J.
        The major histocompatibility complex in man. Past, present and future concepts.
        Science. 1981; 213: 1469
        • Dausset J.
        • Hors J.
        • Busson M.
        • et al.
        Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants. A joint analysis of 918 cases performed by France-Transplant and the London Transplant Group.
        N. Engl. J. Med. 1974; 290: 979
        • Dausset J.
        • Colombani J.
        Histocompatibility Testing 1972.
        Munksgaard, Copenhagen, Denmark1972
        • Dinsmore R.E.
        • Straus D.J.
        • Pollack M.S.
        • et al.
        Fatal graft-versus-host disease following blood transfusion in Hodgkin’s disease documented by HLA typing.
        Blood. 1980; 55: 831
        • Duquesnoy R.J.
        • Filip D.J.
        • Rodey G.E.
        • et al.
        Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients.
        Am. J. Hematol. 1977; 2: 219
        • Ebringer R.W.
        • Cawdell D.R.
        • Cowling P.
        • et al.
        Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.
        Ann. Rheumat. Dis. 1978; 37: 146
        • Ettinger R.B.
        • Terasaki P.I.
        • Opelz G.
        • et al.
        Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens.
        Lancet. 1976; 2: 56
        • Howard J.E.
        • Perkins H.A.
        The natural history of alloimmunization to platelets.
        Transfusion. 1978; 18: 496
        • Moen T.
        • Albrechtsen D.
        • Fiatmark A.
        • et al.
        Importance of HLA-DR matching in cadaveric renal transplantation. A prospective one-center study of 170 transplants.
        N. Engl. J. Med. 1980; 305: 850
        • Moraes J.R.
        • Stastny P.
        A new antigen system expressed in human endothelial cells.
        J. Clin. Invest. 1977; 60: 449

      17. National Institute of Allergy and Infectious Diseases: Manual of Tissue Typing Techniques. Ray, J. G., Jr. (ed.). National Institutes of Health Publication No. 80-545, November, 1979.

      18. Nomenclature for factors of the HLA system 1980. In Terasaki, P. I. (ed): Histocompatibility Testing 1980. Los Angeles, UCLA Tissue Typing Laboratory, 1980, p. 18.

        • Opelz G.
        • Terasaki P.I.
        Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions.
        Lancet. 1974; 2: 696
        • Opelz G.
        • Terasaki P.I.
        International histocompatibility workshop study on renal transplantation.
        in: Terasaki P.I. Histocompatibility Testing 1980. UCLA Tissue Typing Laboratory, Los Angeles1980: 592
        • Persijn G.G.
        • van Leeuwen A.
        • Parlevliet J.
        • et al.
        Two major factors influencing kidney graft survival in Eurotransplant: HLA-DR matching and blood transfusion(s).
        Transplantation Proc. 1981; 13: 150
        • Ryder L.P.
        • Andersen E.
        • Svejgaard A.
        HLA and Disease Registry. Third Report.
        Munksgaard, Copenhagen1979
        • Salvatierra Jr., O.
        • Vincenti F.
        • Amend W.
        • et al.
        Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach.
        Ann. Surg. 1980; 192: 543
        • Schiffer C.A.
        • Aisner J.
        • Daly P.A.
        • et al.
        Alloimmunization following prophylactic granulocyte transfusion.
        Blood. 1979; 54: 766
        • Simon M.
        • Bourel M.
        • Genetet B.
        • et al.
        Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.
        N. Engl. J. Med. 1977; 297: 1017
        • Svejgaard A.
        • Morling N.
        • Platz P.
        • et al.
        HLA and disease associations with special reference to mechanisms.
        Transplantation Proc. 1981; 13: 913
        • Terasaki P.I.
        Resolution by HLA testing of 1,000 paternity cases not excluded by ABO testing.
        J. Fam. Law. 1978; 16: 543
        • Welsh J.
        • Avakian H.
        • Cowling P.
        • et al.
        Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Crossreactivity studies with rabbit antisera.
        Br. J. Exper. Pathol. 1980; 61: 85
        • Yankee R.A.
        • Grumet F.C.
        • Rogentine G.N.
        Platelet transfusion therapy. The selection of compatible platelet donors for refractory patients by lymphocyte HLA-typing.
        N. Engl. J. Med. 1969; 231: 1208

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31057-6

      Copyright

      © 1982 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX